Table 3.
Outcomes | PPI non-users (n = 107,470) | PPI users (n = 53,735) | PSM model 3a | |
---|---|---|---|---|
No. of events (%) | No. of events (%) | HR (95% CI) | P-value | |
All-cause dementia | 907 (0.84) | 497 (0.92) | 1.22 (1.08–1.37) | 0.001 |
Alzheimer’s disease | 321 (0.30) | 180 (0.33) | 1.25 (1.02–1.52) | 0.028 |
Vascular dementia | 223 (0.21) | 132 (0.25) | 1.30 (1.03–1.65) | 0.028 |
Abbreviations: PPI proton pump inhibitor, PSM propensity score matching, HR hazard ratio, CI confidence interval
aPropensity scores were derived from logistic regression, which included age, sex, ethnicity, education, household income, Townsend deprivation index, smoking status, alcohol consumption, physical activity, BMI, occupational exposure, hypertension, coronary heart disease, diabetes, high cholesterol, stroke, traumatic brain injury, depression, anxiety, sleep apnea, cancer, GERD, Barrett’s esophagus, gastroduodenal ulcer, and regular use of medications (statin, antihypertensive drugs, anticholinergic drugs, benzodiazepines, z-hypnotics, aspirin, non-aspirin NSAIDs, multivitamin, and H2RA use)